Erum Yousuf Khan
Overview
Explore the profile of Erum Yousuf Khan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hashmi A, Ajaz Y, Sajjad M, Zia F, Irfan M, Abu Bakar S, et al.
Breast J
. 2025 Feb;
2025:8410670.
PMID: 40008380
Triple-negative breast cancers (TNBCs) constitute a significant proportion of breast cancers in Pakistan. Owing to the lack of expression of hormone (estrogen/progesterone) receptor and human epidermal growth factor receptor 2...
2.
Hashmi A, Mudassir G, Hashmi R, Irfan M, Asif H, Khan E, et al.
Asian Pac J Cancer Prev
. 2019 Sep;
20(9):2601-2606.
PMID: 31554352
Objective: We aimed to investigate the frequency of microsatellite instability (MSI) in endometrial carcinoma in our
population and its association with clinico-pathologic features. Methods: A total of 126 cases of...
3.
Hashmi A, Khan E, Irfan M, Ali R, Asif H, Naeem M, et al.
BMC Res Notes
. 2019 Jan;
12(1):35.
PMID: 30658688
Objectives: T/E fusion results in constitutive expression of ERG oncoprotein resulting in enhanced proliferation and invasive potential of prostatic cancer cells. In the present study we aimed to evaluate the...
4.
Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer
Hashmi A, Naz S, Hashmi S, Hussain Z, Irfan M, Khan E, et al.
BMC Clin Pathol
. 2018 Oct;
18:9.
PMID: 30305801
Background: p16 and p53 genes are frequently mutated in triple negative breast cancer & prognostic value of these mutations have been shown; however, their role as immunohistochemical overexpression has not...
5.
Hashmi A, Hussain Z, Hashmi S, Irfan M, Khan E, Faridi N, et al.
BMC Res Notes
. 2018 Jul;
11(1):433.
PMID: 29970180
Objective: Immunohistochemical over expression of p53 is considered as a marker of poor prognosis in many cancers. Therefore, we aimed to evaluate immunohistochemical overexpression of p53 in 121 cases of...
6.
Hashmi A, Hussain Z, Aijaz S, Irfan M, Khan E, Naz S, et al.
World J Surg Oncol
. 2018 Jun;
16(1):118.
PMID: 29954411
Background: In this study, we intend to determine the immunohistochemical expression of EGFR in cases of head and neck squamous cell carcinoma and its association with prognostic clinico-pathologic features. Methods:...
7.
Hashmi A, Hussain Z, Irfan M, Khan E, Faridi N, Naqvi H, et al.
BMC Urol
. 2018 Jun;
18(1):59.
PMID: 29879970
Background: Epidermal growth factor receptor (EGFR) has been shown to have abnormal expression in many human cancers and is considered as a marker of poor prognosis. Frequency of over expression...
8.
Hashmi A, Ali R, Hussain Z, Faridi N, Khan E, Abu Bakar S, et al.
World J Surg Oncol
. 2017 Jun;
15(1):116.
PMID: 28651545
Background: Microsatellite instability (MSI) operates as the second major pathway in the colorectal carcinogenesis. Although genetic testing remains the gold standard for the detection of MSI, the College of American...